Patent · US Active

Serum half-life extension using IgBD

US10428120B2 · kind B2 · utility

16Cited by

0References

6Claims

0Family size

Assignee

UNIVERSITAT STUTTGART · DE

Inventors

Roland Kontermann · Jeffery Road, DE
Felix UNVERDORBEN · Rötteln, DE
Meike HUTT · Stuttgart, DE

Key dates

Filing date	Jan 19, 2017
Grant date	Oct 1, 2019
Priority date	—
Expiry date	Jan 19, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2319/31
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to complexes comprising (i) an immunoglobulin (Ig) binding moiety and (ii) a pharmaceutically active moiety, wherein the Ig binding moiety specifically binds to the constant domain 1 of the heavy chain (CH1) of an Ig molecule and their use for therapy and prophylaxis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.